This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 1112139
Submitted by lobbyist on: February 26, 2020 08:04:55 AM
Accepted by Registrar on: February 26, 2020 02:42:47 PM
Designated Filer Information
Pacheco, Rhonda |
PO Box 73, Exchange Tower 130 King Street West | |
Toronto, ON, M5X 1B1
|
416-699-7222 |
Canada |
Organization Information
Eli Lilly Canada Inc. |
Eli Lilly is committed to providing answers that matter in medicine, life sciences and health care. As a leading innovation-driven pharmaceutical corporation, Lilly is developing a growing portfolio of products by applying the latest research from its own worldwide laboratories, by collaborating with eminent scientific organizations, by making use of the most up-to-date technological tools and by providing exceptional service to its customers. Headquartered in Indianapolis, Indiana, Lilly provides answers; through medicines and information; for some of the world's most urgent medical needs. Eli Lilly Canada, headquartered in Toronto, Ontario, employs approximately 350 people across the country. Additional information about Eli Lilly Canada can be found at www.lilly.ca. |
PO Box 73, Exchange Tower 130 King Street West | |
Toronto, ON, M5X 1B1
|
416-693-3777 |
Canada |
Relevant Affiliates
Type:
Business Name | Mailing Address | Contact Information |
---|---|---|
Eli Lilly and Company |
Corporate Centre
Indianapolis, IN 46285 United States of America |
Phone: 317-276-2000 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
February 26, 2020 | |
August 26, 2020 |
Organization's In-House Lobbyists
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Policy discussions related to Patented Medicine Prices Review Board (PMPRB) and pharmaceutical pricing, pan-Canadian Pharmaceutical Alliance (pCPA) initiatives, public drug plan reimbursement and design and health system design.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Public Agency | Health | February 26, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Policy discussions related to Patented Medicine Prices Review Board (PMPRB) and pharmaceutical pricing, pan-Canadian Pharmaceutical Alliance (pCPA) initiatives, public drug plan reimbursement and design and health system design.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Public Agency | Health | February 26, 2020 |